Integra LifeSciences

Smith & Nephew has struck a deal to buy the extremity orthopaedics business of Integra LifeSciences for $240 million. The acquisition includes shoulder replacement products and other devices that generated $90 million in revenue last year.

Integra LifeSciences acquired Arkis Biosciences, a neurosurgical devices maker, to expand its neurocritical care and catheter technology markets. The deal includes the CerebroFlo EVD catheter with Endexo technology.

Integra LifeSciences signed a lease for a 110,000-square-foot portion of an industrial building at Cabot Business Park in Mansfield, Massachusetts. Nearly 200 employees from its Raynham site will relocate to the new facility, which will include offices, clean room, R&D space, and manufacturing for neurosurgery products.

The Federal Trade Commission approved Integra LifeSciences' request to purchase DePuy Synthes’ Codman Neuro division.

Integra LifeSciences has made a binding offer to acquire the Codman Neurosurgery business from Johnson & Johnson for $1.045 billion in cash. The acquisition includes a portfolio of devices for hydrocephalus, neuro-critical care, and operative neurosurgery.

Integra LifeSciences has signed a definitive agreement to acquire Derma Sciences for $7.00 per share in cash, expanding its regenerative technology and advanced wound care capabilities. The transaction is expected to close at the end of Q1 2017.